Novo Nordisk’s Legal Blitz and Discounted Ozempic Copy Signal a New Phase in the GLP-1 Wars
The Danish pharmaceutical giant is firing on multiple fronts — in the courtroom, on the pricing front, and…
Novo Nordisk: Reimbursement Milestones and Pill Approval Signal New Growth Levers, But Stock Remains
Novo Nordisk secures French reimbursement and EU oral Wegovy nod, but shares plunge 35% as US competition and…
Novo Nordisk Dual Obesity Data and Odense Retooling Signal Strategic Pivot
Novo Nordisk presents promising obesity trial results for high-dose Wegovy and oral semaglutide, while restructuring manufacturing in Odense…
Novo Nordisk Streamlines Metabolism Focus as Menopause Data and Analyst Upgrade Signal Turnaround
Novo Nordisk sheds last cell therapy asset to focus on metabolic diseases, as Hedgeye predicts 52-117% upside and…
BYD’s Beijing Reveal and Brussels Bid Signal a Two-Speed Global Strategy
BYD unveils a redesigned Atto 3 EV with 5-minute fast charge to counter a 73% sales drop in…
OnePlus 15T bets on G2 esports chip for stable gaming performance
ⓘ OnePlus The OnePlus 15T is said to sport a 360° surround high-performance antenna setup. Pictured: the phone…